CPHL has initiated the establishment of ashAshoequivalence centres in Pakistan

Citi Pharma Ltd (CPHL) conducted its analyst briefing session today to discuss business performance and outlook, as reported by Topline Pakistan Research. The company’s biotech insulin manufacturing plant, currently in…

Continue ReadingCPHL has initiated the establishment of ashAshoequivalence centres in Pakistan

Pakistan listed pharmaceuticals sector’s earnings were up by 30% YoY to Rs 10.4 bn in 1QFY26

Topline Pakistan Research has released a report on Pakistan Pharmaceuticals and noted that the listed Pharma Profit was up 30% YoY in 1QFY26, and likely Momentum continued with improved margins.…

Continue ReadingPakistan listed pharmaceuticals sector’s earnings were up by 30% YoY to Rs 10.4 bn in 1QFY26

Martin Dow receives DRAP establishment license for clinical chemistry reagents re-filling and labelling

Martin Dow has received an establishment license from the Drug Regulatory Authority of Pakistan (DRAP) for re-filling and labelling of its new clinical chemistry reagents down-filling facility. This marks an…

Continue ReadingMartin Dow receives DRAP establishment license for clinical chemistry reagents re-filling and labelling

Lucky Core Industries expects Pfizer’s acquisition in Sept 2024

Topline Securities hosted Pakistan Pharma Invest 2024, the third session of which was Lucky Core Industries (LCI) Limited. Mr. Atif Aboobukar, LCI's CFO, spoke at the session. Regarding the pharmaceutical…

Continue ReadingLucky Core Industries expects Pfizer’s acquisition in Sept 2024